Animal models are essential tools in the study of orofacial clefting. Our understanding of the molecular genetic mechanisms of clefting has been informed to a great extent by such models. In this study, the authors have developed a new animal model of cleft palate in mice using the technique of transgene insertion mutagenesis. This new animal model will allow the study of various signal transduction pathways that are known to be involved in development of the secondary palate from a new point in those pathways. As such, this model has the potential to significantly advance our understanding of the etiology of clefting of the secondary palate.
occurs when there is transformation of the medial edge epithelia (MEE) along with remodeling of the extracellular matrix. Perturbation of this complex cascade of events can lead to cleft palate (CP) (Ferguson, 1988) . Nonsyndromic CP (i.e., no other recognizable defects or disabilities) represents a common clinical outcome of genetically heterogeneous etiologies. A growing number of genes that encode transcription factors, signaling molecules, growth factors, growth factor receptors, and extracellular matrix proteins have been implicated in the pathogenesis of syndromic and nonsyndromic orofacial clefts (Schutte and Murray, 1999; Chong et al., 2002; Lidral et al., 2008; Marazita et al., 2009; Shi et al., 2009) . Transgene insertional mutagenesis is a common occurrence during the generation of transgenic mice (Meisler, 1992) and has led to the identification of a number of developmentally important genes (Shawlot et al., 1989; Bishop et al., 2000; Overbeek et al., 2001; Cunningham et al., 2002) .
Adaptor protein (AP) complexes are composed of subunits (adaptins) that are involved in the formation of intracellular transport vesicles and in the selection of cargo for incorporation into vesicles (Boehm and Bonifacino, 2001) . Several heterotetrameric adaptor complexes (AP-1, AP-2, AP-3, and AP-4) are associated with vesicles. Adaptor complexes contain adaptin proteins (a, c, d, or e and b1, b2, or b4, respectively) that are linked to a medium chain (m1, m2, m3, or m4) and one small chain (s1, s2, s3, or s4). The AP-2 adaptor complex (a, b2, m2, and s2) is key to successful clathrin-dependent endocytosis from the plasma membrane; whereas, the AP-1 adaptor complex (c, b1, m1, and o1) is associated with the trans-Golgi network and endosomes (Traub, 1997 (Traub, , 2003 Robinson, 2004) . The Ap2b1 gene located on mouse chromosome 11 encodes the AP-2 complex subunit beta-1 protein (AP2B1, UniProtKB/Swiss-Prot Q9DBG3). AP2B1 has been widely studied under several alternative names including adaptorrelated protein complex 2 beta-1 subunit, b2-adaptin, badaptin, plasma membrane adaptor HA2/AP2 adaptin beta subunit, clathrin assembly protein complex 2 beta large chain, and AP105B. The Ap1b1 gene encodes the AP-1 complex subunit beta-1 (AP1B1, UniProtKB/Swiss-Prot O35643). Common alternative names for AP1B1 include adaptor-related protein complex 1 subunit beta-1, adaptor protein complex AP-1 subunit beta-1, b-prime adaptin 1, b1-adaptin, Golgi adaptor HA1/AP1 adaptin beta subunit, clathrin assembly protein complex 1 beta large chain, and AP105A. To minimize confusion the common alternate names for the products of the Ap2b1 and Ap1b1 genes, b2adaptin and b1-adaptin, respectively, are used through this present study.
Herein we report the use of transgene insertional mutagenesis to show that disruption of the Ap2b1 gene encoding of the b2-adaptin subunit of the AP-2 complex causes perinatal mortality and nonsyndromic CP.
METHODS

Generation of Transgenic Mice
Transgenic mice were generated by microinjection of a tyrosinase minigene (TYBS) into single-cell mouse embryos ( Fig. 1A) (Yokoyama et al., 1990; Overbeek et al., 1991) . Albino FVB/NJ female mice mated to FVB/NJ males were used as embryo donors. Outbred ICR females bred to vasectomized (C57BL/6J 3 DBA/2J)F1 males were used as embryo recipients and surrogate mothers. All the animal experiments were performed with the approval of the Indiana University School of Dentistry and Baylor College of Medicine Animal Care and Use Committees.
Genotyping of Transgenic Mice
The identification of transgenic mice was made initially by the presence of coat color and pigmented eyes. The BALB/c promoter driving the tyrosinase complementary DNA (cDNA) in the tyrosinase minigene provides rescue of the albino phenotype of FVB/NJ mice (Yokoyama et al., 1990; Overbeek et al., 1991) . The presence of the transgene in genomic DNA also was confirmed by standard polymerase chain reaction (PCR) using GeneAmpH PCR reagents (Applied Biosystems, Foster City, CA) and TYBSspecific primers (TYBS 636F ctgaaatatggagggacattgatt and TYBS1034R tcaaactcagacaaaattccacatt) to amplify a 400base pair (bp) portion of the TYBS transgene. These primers do not amplify the endogenous Tyr gene located on chromosome 7. Tg/+ and Tg/Tg embryos were distinguished using TaqManH Gene Expression Assays (Applied Biosystems). Total cellular RNA was prepared from whole embryos using the RNAqueous-4PCR kit (Ambion, Austin, TX) and reverse transcribed to cDNA, High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) followed by TaqManH Gene Expression Assays using TaqManH Universal PCR Master mix (Applied Biosystems), Ap2b1 (Mm00551136_m1), and Pgk (Mm00435617_m1), as an endogenous control.
Genomic Library Construction and Screening
Genomic DNA was prepared from a pool of three homozygous OVE427 CP embryos using the Pure TM Tissue DNA Isolation Systems (DNA Technologies, Inc., Gaithersburg, MD). Following partial digestion with Sau3AI, the DNA was size-fractionated using sucrose gradients into two size ranges (9.0 to 13.0 thousand base pairs [kbp] and 13.0 to 23.0 kbp) and then ligated to BamHI digested EMBL3 vectors, packaged using Gigapack III packaging extract, and plated on the XL1-Blue MRA (P2) strain (Stratagene, La Jolla, CA). Libraries contained ,5 to 8 3 10 6 clones and unamplified titers of ,1 3 10 10 plaqueforming unit (pfu)/mL. Aliquots of the unamplified 9.0-to-13.0-kbp and 13.0-to-23.0-kbp libraries were screened using PCR (primers described above). The PCR-positive OVE427 library containing 13.0-to-23.0-kbp inserts was plated and the plaque lysates screened by PCR. PCR-positive plates were then subjected to a minimum of three rounds of plaque purification using nonisotopic DNA-DNA hybridization with a digoxigenin (DIG)-labeled TYBS minigene fragment as a probe (DIG-High Prime DNA labeling) and chemiluminescent detection (Roche Diagnostics Corporation, Indianapolis, IN). Two clones were chosen for subsequent amplification and subcloning in pBluescript (Stratagene).
Northern Analyses
Total cellular RNA was prepared from OVE427 Tg/Tg, Tg/+, and wildtype (+/+) whole embryos 18 days post coitum or adult OVE427 +/+ tissues using Tri-Reagent (Molecular Research Center, Cincinnati, OH). Twenty to 35 mg of RNA was separated using a denaturing formaldehyde-1.5% agarose gel and transferred to a MagnaGraph nylon membrane (M.S.I., Westboro, MA). Filters were prehybridized/hybridized using DIG Easy Hyb (Roche Diagnostics Corporation, Indianapolis, IN) and a DIG-labeled cocktail of Ap2b1 C-terminal and N-terminal probes subcloned from a full length Ap2b1 cDNA probe (Open Biosystems, Huntsville, AL), washed at high stringency (0.53 SSC/0.1% wt/vol sodium dodecyl sulfate [SDS] at 62uC), then used for chemiluminescent detection on Fuji Super RX medical x-ray film (Fujifilm Medical Systems, Stamford, CT). The membranes were subsequently stripped and reprobed with a DIG-labeled mouse b-actin probe.
Mouse Embryonic Fibroblasts
Skin from the dorsum of E17-E18 embryos generated by crossing wildtype (+/+) with OVE427 heterozygotes (Tg/+) and by crossing Tg/+ by Tg/+ was finely minced and placed in DMEM (Gibco, Grand Island, NY) containing 4.5 g/L D-glucose, L-glutamine, sodium pyruvate, 10% FCS (Sigma-Aldrich, St. Louis, MO), and Pen/Strep (Sigma-Aldrich). Cells were cultured at 37uC/5% CO2 and passaged by lifting with 0.5 g/L trypsin and 0.2g/L EDTA (Sigma-Aldrich) when cells reached 80% confluence.
Antibodies
Mouse anti-b2 adaptin, mouse anti-a (A isoform) (Robinson, 1989) , and mouse anti-c (c1 isoform) monoclonal antibodies (BD Transduction Laboratories, San Jose, CA) were used for immunoblotting and immunoprecipitations in conjunction with horseradish peroxidase (HRP)-conjugated anti-mouse or anti-rabbit IgG (GE Healthcare/Amersham Bioscience, Piscataway, NJ). For immunofluorescence mouse anti-a (Affinity BioReagents, Golden, CO); rabbit anti-epsin, a gift from Dr. Linton Traub (University of Pittsburgh School of Medicine, Pittsburgh, PA); rabbit and mouse antibodies anti-b1+b2 provided by Dr. James Keen (Kimmel Cancer Institute, Philadelphia, PA) and Dr. Tomas Kirchhausen (Harvard Medical School, Boston, MA), respectively, were used in conjunction with goat anti-mouse or goat anti-rabbit IgG conjugated to Alexa Fluor 488 or 555 (Molecular Probes, Eugene, OR).
Immunofluorescence Microscopy
Wild-type (+/+) and homozygous mutant (Tg/Tg) mouse embryonic fibroblasts (MEFs) were grown on coverslips and fixed in methanol/acetone (1:1, vol/vol) for 10 minutes at 220uC. Incubation with primary antibodies diluted in phosphate buffered saline (PBS), 0.1% wt/vol saponin, and 0.1% wt/vol body surface area (BSA) was carried out for 1 hour at room temperature. Unbound antibodies were removed by rinsing with PBS for 5 minutes, and cells subsequently were incubated with secondary antibody (Alexa555-or Alexa488-conjugated goat anti-rabbit or anti-mouse immunoglobulin) diluted in PBS, 0.1% wt/vol saponin, and 0.1% BSA, for 30 to 60 minutes at room temperature. After a final rinse with PBS, coverslips were mounted onto glass slides with Fluoromount G (Southern Biotechnology Associates, Birmingham, AL). Fluorescence images were acquired on an LSM 510 confocal microscope (Carl Zeiss, Thornwood, NY).
Immunoblotting and Immunoprecipitation
Fibroblasts were washed with ice-cold PBS, extracted in ice-cold lysis buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% vol/vol Triton X-100) supplemented with a protease inhibitor cocktail, Sigma P-8340 (Sigma-Aldrich Co., St. Louis, MO), centrifuged at 16,000 3 g for 10 minutes, and supernatants were collected. For immunoprecipitation, lysates were incubated with 5 mL of anti-a (Affinity BioReagents) and protein G-Sepharose (Amersham Bioscience, Piscataway, NJ) at 4uC overnight. Immunoprecipitates were then collected, washed four times with PBS, and eluted by incubation with Laemmli sample buffer (2% wt/vol SDS, 10% vol/vol glycerol, 5% vol/vol 2mercaptoethanol, 0.002% vol/vol bromophenol blue and 0.0625 M Tris-HCl, pH 6.8) for 10 minutes at room temperature. Samples were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) (4% to 20% gradient gels) under reducing conditions and transferred onto nitrocellulose. The membranes were then blocked with 13 PBS, 0.05% vol/vol Tween-20, and 10% wt/vol nonfat milk and incubated with the appropriate antibodies. Enhanced chemiluminescence reagent (Amersham Biosciences) was used for protein detection.
RESULTS
Cleft Palate Mutant Strain Developed by Insertional Mutagenesis
The transgenic line OVE427 was found to have perinatal lethality when bred to homozygosity. Complete clefting of the secondary palate was observed in 25% of late gestation embryos produced from intercrossing heterozygous OVE427 Tg/+ mice (Fig. 2) . No craniofacial dysmorphology or any anomalies involving the limbs or developing skeleton were noted. Coronal cross-sections of the secondary palate of Tg/Tg embryos at E17 and E18 showed evidence of palatal shelf elevation and the apparent failure of the shelves to fuse. Additional histological examination through serial cross-sections of entire embryos did not reveal differences in major internal organs (heart, brain, lungs, kidneys, and gastrointestinal tract) between wildtype and homozygous littermates other than CP (data not shown).
Identification of the Ap2b1 Gene as the CP Locus
Following SalI digestion of a single OVE427 lambda clone, four DNA fragments of approximately 20, 9, 8, and 5 kbp were identified. Southern transfer and hybridization using the TYBS minigene fragment revealed hybridization signals over the 5 and 8 kbp bands and not the 9 and 20 kbp bands (data not shown). The 9 and 20 kbp bands corresponded to the expected sizes of the lambda EMBL3 vector arms. DNA sequencing inward from the EMBL3 vector arms in the undigested lambda clone and of the 5 and 8 kbp SalI bands subcloned into pBluescript (Stratagene) was performed. The SalI fragments were subjected to secondary digestion using XbaI, and those resultant fragments were subcloned and subjected to DNA sequencing. Sequences were analyzed by BLASTH (Basic Local Alignment Search Tool) (http://blast.ncbi.nlm.nih.gov/ Blast.cgi) using the megaBLAST program (compares highly related nucleotide sequences) against all mouse genome assemblies (http://www.ncbi.nlm.nih.gov/genome/ seq/BlastGen/databases.shtml). From the left arm a 2.3kbp genomic DNA fragment at 99% identity mapped to chromosome 11 and corresponded to intronic sequence between exons 1 and 2 of the Ap2b1 (adaptor protein complex 2 b1 subunit) gene (Fig. 1B) . From the right arm a 4.2-kbp genomic DNA fragment at 99% identity mapped to chromosome 11 and corresponded to intronic sequence between exons 14 and 15 of the Ap2b1 gene. These intronic sequences were inverted in orientation in the clone and normally reside ,50 kbp apart in the Ap2b1 gene. Sequencing within and between the TYBS transgene in this clone confirmed its presence and indicated that two copies of the TYBS transgene integrated in the genome.
Absence of Ap2b1 Transcript in Homozygous Mutant Mice
We next investigated Ap2b1 gene expression by Northern blot. A ,5.8-kbp Ap2b1 transcript was detected in wildtype (+/+) and heterozygous (Tg/+) embryos but not in RNA prepared from homozygous mutant (Tg/Tg) embryos (Fig. 3) . The Ap2b1 transcript was reduced in intensity in the heterozygote when compared with wildtype. A multitissue Northern blot showed Ap2b1 to be widely expressed in wildtype mice, including palatal tissue and with greatest expression in the brain (Fig. 4) .
Absence of b2-Adaptin Protein in Cells and Tissues From Homozygous Mutant Mice
The Ap2b1 gene encodes a protein named b2-adaptin that, together with a-adaptin, m2, and s2, assemble into the heterotetrameric adaptor protein-2 (AP-2) complex involved in clathrin-dependent endocytosis (Boehm and Bonifacino, 2002; Kirchhausen, 2002; Robinson, 2004) . Consistent with the Northern analysis, immunoblot analysis with an antibody specific to b2-adaptin revealed the absence of this protein in mouse embryonic fibroblasts (MEFs) (Fig. 5A) and tissues (i.e., brain and liver) ( Fig. 5B ) from homozygous mutant (Tg/Tg) animals. MEFs and tissues from heterozygous (Tg/+) mice exhibited reduced levels (,50%) of b2-adaptin relative to those from wildtype mice. Immunoblot analysis of wildtype MEFs with two different antibodies that recognize both b2adaptin and the homologous b1-adaptin subunit of the AP-1 complex showed a doublet corresponding to the fastermigrating b2 and the more slowly migrating b1 (Fig. 5A) . MEFs from heterozygous mice exhibited reduced levels of b2 and unchanged levels of b1; whereas, those from homozygous mutant mice showed only one expression ( Fig. 5A ). Levels of a-adaptin were reduced in homozygous mutant MEFs (Fig. 5A) and tissues (Fig. 5B ), suggesting that the absence of b2-adaptin partially destabilizes aadaptin. In contrast, the levels of the c-adaptin subunit of AP-1 were unchanged (Fig. 5A) . These analyses thus showed that homozygous mutant mice did not synthesize any b2-adaptin and that this deficiency coincided with reduced the levels of a-adaptin.
Partial Substitution of b1-Adaptin for b2-Adaptin in Homozygous Mutant Mice
To examine the assembly status of a-adaptin in MEFs from wildtype, heterozygous, and homozygous mutant mice, we performed immunoprecipitation of a-adaptin from cell lysates followed by immunoblotting with an antibody that recognizes both b1 and b2 (Fig. 5C ). We found that in wildtype MEFs, a coprecipitated almost exclusively with b2, as expected for two subunits of the AP-2 complex (Fig. 5C ). Strikingly, a coprecipitated with equal amounts of b2 and b1 in heterozygous cells, and only with b1 in homozygous mutant cells (Fig. 5C ). This indicates that b1 can substitute for b2 in the AP-2 complex. The amount of b1 coprecipitated with a in homozygous mutant cells was higher than that in wildtype cells (in which there is b2) (Fig. 5C ). This means that under normal conditions a prefers to assemble with b2 over b1, but accepts b1 when there is no b2. FIGURE 4 Multi-tissue Northern blot analysis of mouse Ap2b1 and bactin transcripts in total RNA. Thirty-five micrograms of total RNA were blotted in each lane. The blot was hybridized with a cocktail of Ap2b1 Cterminal and N-terminal probes, stripped, and rehybridized with a 600-bp murine b-actin probe. Tissues surveyed were the liver, spleen, skin, brain, skeletal muscle, tongue, hard palate, heart, kidney, and lung.
Normal Distribution of the Variant AP-2 Complex Containing b1-Adaptin
We next examined by immunofluorescence microscopy the distribution of the variant AP-2 complex containing b1adaptin in wildtype (+/+) and homozygous mutant (Tg/Tg) MEFs. We observed that a-adaptin localized to punctate foci at the plasma membrane corresponding to clathrincoated pits in both wildtype and homozygous mutant MEFs (Fig. 6A and 6B) . It is interesting that whereas in wildtype cells, b1-adaptin localizes to the trans-Golgi network (TGN) (Robinson, 2004 , and data not shown), in homozygous mutant MEFs b1-adaptin was found on both the TGN and plasma membrane puncta ( Fig. 6D and  6G) . These puncta, but not the TGN structure, contained another plasma membrane clathrin-associated adaptor, epsin 1 (Fig. 6C and 6F) , identifying them as clathrincoated pits and vesicles. b1-adaptin (green) and epsin (red) overlap in expression (yellow) (Fig. 6E and 6H ). From these experiments we concluded that incorporation into the AP-2 complex draws b1 to plasma membrane clathrincoated pits and that the substitution of b1 for b2 in the AP-2 complex has no detectable effect on the localization of this complex.
DISCUSSION
We have identified a new mouse transgenic insertional mutant that results in autosomal recessive nonsyndromic CP. The transgene integration site is located within the Ap2b1 gene on chromosome 11, disrupting the genomic organization. Homozygous (Tg/Tg) embryos lack expression of the Ap2b1 gene as well as the b2-adaptin protein.
Heterozygous (Tg/+) embryos express roughly half the level of wildtype Ap2b1 transcripts and are completely normal. The Ap2b1 gene is widely expressed in adult mice, including the hard palate, and is most abundant in brain.
The mechanism by which the loss of b2-adaptin function leads to CP is not entirely clear. A subunit of the heterotetrameric AP-2 complex, b2-adaptin is involved in clathrin-dependent endocytosis of receptors from the plasma membrane (Kirchhausen, 2002; Robinson, 2004) . It is thus likely that CP in b2-adaptin-mutant mice results from defective endocytosis of one or more receptors or other cell surface proteins involved in palatogenesis. TGF-b superfamily members regulate a wide range of biological processes by binding to two transmembrane serine/threonine kinase receptors (Feng and Derynck, 2005) . The TGFbeta/Smad signaling pathway is known to play a critical role during the process of epithelial-mesenchymal transformation of MEE in palatogenesis (Cui and Shuler, 2000; Tudela et al., 2002; Cui et al., 2003; Cui et al., 2005; Nakajima et al., 2007) . Disruption of TGF-beta signaling can lead to cleft palate (Proetzel et al., 1995; Sanford et al., 1997) . Ligand binding leads to both signal transduction and receptor downregulation. TGF-b receptor downregulation has been shown to occur through concentration within clathrin-coated pits and internalization into clathrin-coated vesicles for eventual delivery to endosomes (Anders et al., 1997; Anders et al., 1998; Ehrlich et al., 2001; Yao et al., 2002) . Clathrin-mediated endocytosis of TGF-b receptors depends on the interaction of their cytosolic tails with the b2-adaptin subunit of AP-2 (Yao et al., 2002) . This interaction is in contrast to that of other endocytic receptors, which bind to the m2 subunit (Ohno et al., 1995; Boll et al., 1996; Ohno et al., 1996) or a combination of the a and s2 subunits of AP-2 (Chaudhuri et al., 2007; Doray et al., 2007; Mitchell et al., 2008) . It is likely that the absence of b2-adaptin impairs internalization of TGF-b receptors from the cell surface, resulting in either sustained signaling from the plasma membrane or decreased signaling from the endosomes (Hayes et al., 2002; Itoh et al., 2002; Di Guglielmo et al., 2003; Runyan et al., 2005) . Therefore, the CP phenotype of the b2-adaptin-deficient mice might result in part from perturbation of TGF-b signaling.
FIGURE 6 b1 subunit is partially incorporated into AP-2 complexes in Ap2b1 mutant mice. A, B: Wild-type (+/+) and homozygous (Tg/Tg) mouse embryonic fibroblasts were grown on coverslips, fixed in methanol:acetone (1:1), and stained with mouse monoclonal antibodies against a followed by Alexa488-conjugated goat anti-mouse IgG. Cells were examined by confocal fluorescence microscopy. Scale bar, 10 mm. C through E: (Tg/Tg) fibroblasts were fixed and double-stained with antibodies against epsin (red) (C) and b1 (green) (D). Bound antibodies were revealed by Alexa-488 conjugated antibody to mouse IgG and Alexa-555-conjugated antibody to rabbit IgG. All images were obtained by confocal microscopy. Merging images in the red and green channels generated the third panel (E and H) on each row; yellow indicates overlapping localization. F, G, and H: Two-fold magnification of the regions shown in panels C, D, and E. Scale bar = 10 mm.
Perturbation of c-aminobutyric acid (GABA)-activated signaling also leads to CP (Homanics et al., 1997; Hagiwara et al., 2003) . It is interesting that GABA(A) receptors cycle between the synaptic membrane and intracellular sites; their AP-2-dependent recruitment into clathrin-coated pits represents an important mechanism in the postsynaptic modulation of inhibitory synaptic transmission (Kittler et al., 2000; Herring et al., 2003; Kittler et al., 2005) . Therefore, defective GABA(A) receptor internalization and signaling due to the presence of the variant, b1adaptin-containing AP-2 complex could also contribute to the CP phenotype of the b2-adaptin-deficient mice.
In addition to the substitution of b1-adaptin for b2adaptin, the lower levels of the variant AP-2 complex (,50%, as inferred from the levels of a-adaptin) in the b2deficient mice could also be a contributing factor leading to CP. Such substitution of b1-adaptin for b2-adaptin has been observed (Keyel et al., 2008) . Of note, heterozygous m2deficient mice also have reduced levels of the b2-adaptin AP-2 complex (,70% of a-adaptin levels seen in wildtype) but display no phenotypic abnormalities (Mitsunari et al., 2005) .
Homozygous b2-adaptin-deficient embryos survive development and die perinatally due to CP. This phenotype contrasts sharply with that of homozygous m2-deficient embryos, which die before day 3.5 post coitum (Mitsunari et al., 2005) . As shown here, the reason for the different outcomes likely lies in the unique ability of b1-adaptin to substitute for b2-adaptin in the AP-2 complex. Indeed, mouse b1-and b2-adaptins are 84% identical in amino acid sequence, a level that to a large extent allows them to behave as interchangeable subunit isoforms (Ahle et al., 1988; Kirchhausen et al., 1989; Ponnambalam et al., 1990; Guilbaud et al., 1997; Boehm and Bonifacino, 2001) . This notion is supported by previous work showing that both b1and b2-adaptins promiscuously interact with other subunits from AP-1 and AP-2 in coprecipitation and yeast two-hybrid analyses (Page and Robinson, 1995) . An extreme case is Drosophila melanogaster, in which a single b1/2-adaptin is a component of both AP-1 and AP-2 (Camidge and Pearse, 1994) . The situation is different for the other three subunits of AP-1 and AP-2, which exhibit 29% to 45% amino acid sequence identity and are not interchangeable (Page and Robinson, 1995) . Thus, the inability of m1 to be incorporated into the AP-2 complex likely accounts for the early embryonic lethality observed with m2 deficiency (Mitsunari et al., 2005) . The converse is also the case because m2 does not assemble into the AP-1 complex in m1A-deficient mice, resulting in midgestation embryonic lethality (Meyer et al., 2000) . Thus, the survival of b2-adaptin-deficient embryos until birth likely results from the rescue of most AP-2 functions by substitution with b1-adaptin.
